{"success":true,"data":{"pressRelease":{"id":"167406","rtpr_id":"nGNXcf8blV-20261013","ticker":"RSCF","exchange":"OTC","all_tickers":["RSCF"],"title":"Reflect Scientific Introduces PF-90 Blast Plate Freezer, Combining Two Freezing Technologies for Biopharmaceutical and Cell Therapy Applications","author":"Globe Newswire","published_at":"2026-10-13T12:00:00.268Z","article_body":"OREM, Utah, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc.\n(Symbol: RSCF), through its Cryometrix brand, today announced the launch of\nthe PF-90 Blast Plate Freezer, a next-generation ultra-low temperature system\nengineered to combine liquid nitrogen (LN2) blast freezing with conductive\nplate freezing in a single unit. The PF-90 is designed for facilities handling\nbiopharmaceuticals, biologics, vaccines, plasma, blood products, cell and gene\ntherapy materials, pharmaceutical drug substances, and other bioprocessing\nmaterials that require rapid, uniform, and repeatable freezing. The PF-90 is\npatent pending.\n\nTwo Freezing Methods, One System\n\nHistorically, facilities have had to choose between blast freezers, which use\nhigh-velocity ultra-cold air and are well suited to mixed or irregularly\nshaped loads, and plate freezers, which use direct-contact cooling plates on\nspecific bag types to achieve uniform, flat-frozen bags. The PF-90 eliminates\nthat tradeoff by integrating both technologies into a single platform,\nallowing operators to select the optimal method for each application while\nreducing capital costs, floor space requirements, and operational complexity.\n\n“Plate freezing has become a necessary method for many biologics and blood\nproduct applications because it delivers faster heat transfer, improved\nuniformity across bag thickness, and reduced ice crystal formation,” the\ncompany noted, pointing to the reproducibility that regulated environments\nrequire.\n\nKey Specifications\n* Temperature range: 40°C to -90°C\n* Peak variation from setpoint: ±2°C\n* Pull-down time: Approximately 10 minutes from ambient to -80°C (empty\npayload bay)\n* Door-opening recovery: Approximately 1 minute to return to -80°C after\ndoors are open for 3 minutes\n* Payload bay: 578 mm (D) x 800 mm (W) x 1,524 mm (H)\n* Exterior dimensions: 1,062 mm (D) x 1,224 mm (W) x 2,388 mm (H); weight\napproximately 738 kg (1,626 lbs)\n* Construction: 304 stainless steel, interior and exterior\n* Capacity: Up to 8 Sartorius Celsius FFTp 12 L bags (or equivalent) per\nfreeze cycle, at 10 liters fill volume per bag; 192 L in bottles; alternative\ncontainer configurations available on request\n* Electrical: 120V-220V, 60 Hz, NEMA 5-20 plug, 12A max\n* LN2 system: 100-125 psi supply pressure, CGA 295 male inlet fitting\n* Data logging: Standard on-board datalogging with manual CSV export\n* Access control: Three standard user security levels supporting up to 100\nindividual users (expandable with IPC upgrade)\n* Backup systems: Optional, up to 3 hours\n* Certifications: CE-compliant product; optional 21 CFR Part 11 compliance\npackage available\n* Warranty: 20 years on the cooling system, including control valve\nreplacement, with virtual technical support\n* Origin: Designed and manufactured in the USA\nThe PF-90's cooling system is powered by Cryometrix's proprietary LN2\ntechnology, which does not rely on compressors or circulated refrigerants. The\ncompany states this design reduces common mechanical failure points, lowers\nelectrical demand compared to compressor-based systems, and reduces heat\noutput to surrounding HVAC infrastructure.\n\nTarget Applications\n\nThe PF-90 is intended for use in biopharmaceutical manufacturing, blood\nbanking and transfusion centers, cell and gene therapy facilities, and\nresearch laboratory environments where even small variations in freezing\nconditions can affect product integrity and regulatory compliance.\n\nMarket Context\n\nDemand for ultra-low temperature freezing equipment continues to grow\nalongside expansion in biologics, cell and gene therapy, and blood product\nprocessing. Industry research estimates the global blast freezer market at\n$1.84 billion in 2025, growing to approximately $1.94 billion in 2026, and\nprojected to reach $2.58 billion by 2032 at a compound annual growth rate of\n4.89%. Separately, the global biomedical refrigerator and freezer market has\nbeen estimated at $4.34 billion in 2025, growing to approximately $4.8 billion\nin 2026 at a compound annual growth rate of 10.6%, with growth attributed in\npart to expanding vaccine storage needs, blood and plasma storage\nrequirements, and temperature-controlled drug development activity. Market\nsize estimates vary by research firm and market definition, and figures should\nbe considered directional rather than authoritative.\n\nAvailability\n\nPricing for the PF-90 is available upon request. Interested parties can\ncontact Cryometrix directly at (801) 226-4100 or info@cryometrix.com.\n\nAbout Reflect Scientific, Inc.\n\nReflect Scientific, Inc., based in Orem, Utah, develops and markets\ninnovative, proprietary technologies in cryogenic cooling for the\nbiotechnology, pharmaceutical, medical, and transportation markets. Among\nReflect Scientific’s products are low-temperature freezers and refrigerated\nsystems for laboratory, transportation, and computer server room uses. Visit\nreflectscientific.com (http://reflectscientific.com) for more information. See\nus on Twitter @ReflectSci and LinkedIn\nwww.linkedin.com/company/reflect-scientific.\n\nForward-Looking Statements\nThis press release contains forward-looking statements within the meaning of\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended. Forward-looking statements are\nnot a guarantee of future performance or results, and will not necessarily be\naccurate indications of the times at, or by, which such performance or results\nwill be achieved. Forward-looking statements are based on information\navailable at the time the statements are made and involve known and unknown\nrisks, uncertainties and other factors that may cause our results, levels of\nactivity, performance or achievements to be materially different from the\ninformation expressed or implied by the forward-looking statements in this\npress release. This press release should be considered in light of the\ndisclosures contained in the filings of the Company that are contained in the\nOTC Markets Group, LLC under the trading symbol “RSCF” and related prior\nfilings by the Company that are referenced therein and contained in the EDGAR\nArchives of the Securities and Exchange Commission under the heading\n“Disclosure,” including those identified in such filings as\n“forward-looking statements.”\n\nContact\nInvestor Relations\n801-607-1039\ninfo@reflectscientific.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/28066f8b-1063-44c2-9ce7-c35fa2d74e58)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXcf8blV-20261013","title":"Reflect Scientific Introduces PF-90 Blast Plate Freezer, Combining Two Freezing Technologies for Biopharmaceutical and Cell Therapy Applications","author":"Globe Newswire","ticker":"RSCF","created":"2026-10-13T12:00:00.268Z","tickers":["RSCF"],"exchange":"OTC","article_body":"OREM, Utah, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc.\n(Symbol: RSCF), through its Cryometrix brand, today announced the launch of\nthe PF-90 Blast Plate Freezer, a next-generation ultra-low temperature system\nengineered to combine liquid nitrogen (LN2) blast freezing with conductive\nplate freezing in a single unit. The PF-90 is designed for facilities handling\nbiopharmaceuticals, biologics, vaccines, plasma, blood products, cell and gene\ntherapy materials, pharmaceutical drug substances, and other bioprocessing\nmaterials that require rapid, uniform, and repeatable freezing. The PF-90 is\npatent pending.\n\nTwo Freezing Methods, One System\n\nHistorically, facilities have had to choose between blast freezers, which use\nhigh-velocity ultra-cold air and are well suited to mixed or irregularly\nshaped loads, and plate freezers, which use direct-contact cooling plates on\nspecific bag types to achieve uniform, flat-frozen bags. The PF-90 eliminates\nthat tradeoff by integrating both technologies into a single platform,\nallowing operators to select the optimal method for each application while\nreducing capital costs, floor space requirements, and operational complexity.\n\n“Plate freezing has become a necessary method for many biologics and blood\nproduct applications because it delivers faster heat transfer, improved\nuniformity across bag thickness, and reduced ice crystal formation,” the\ncompany noted, pointing to the reproducibility that regulated environments\nrequire.\n\nKey Specifications\n* Temperature range: 40°C to -90°C\n* Peak variation from setpoint: ±2°C\n* Pull-down time: Approximately 10 minutes from ambient to -80°C (empty\npayload bay)\n* Door-opening recovery: Approximately 1 minute to return to -80°C after\ndoors are open for 3 minutes\n* Payload bay: 578 mm (D) x 800 mm (W) x 1,524 mm (H)\n* Exterior dimensions: 1,062 mm (D) x 1,224 mm (W) x 2,388 mm (H); weight\napproximately 738 kg (1,626 lbs)\n* Construction: 304 stainless steel, interior and exterior\n* Capacity: Up to 8 Sartorius Celsius FFTp 12 L bags (or equivalent) per\nfreeze cycle, at 10 liters fill volume per bag; 192 L in bottles; alternative\ncontainer configurations available on request\n* Electrical: 120V-220V, 60 Hz, NEMA 5-20 plug, 12A max\n* LN2 system: 100-125 psi supply pressure, CGA 295 male inlet fitting\n* Data logging: Standard on-board datalogging with manual CSV export\n* Access control: Three standard user security levels supporting up to 100\nindividual users (expandable with IPC upgrade)\n* Backup systems: Optional, up to 3 hours\n* Certifications: CE-compliant product; optional 21 CFR Part 11 compliance\npackage available\n* Warranty: 20 years on the cooling system, including control valve\nreplacement, with virtual technical support\n* Origin: Designed and manufactured in the USA\nThe PF-90's cooling system is powered by Cryometrix's proprietary LN2\ntechnology, which does not rely on compressors or circulated refrigerants. The\ncompany states this design reduces common mechanical failure points, lowers\nelectrical demand compared to compressor-based systems, and reduces heat\noutput to surrounding HVAC infrastructure.\n\nTarget Applications\n\nThe PF-90 is intended for use in biopharmaceutical manufacturing, blood\nbanking and transfusion centers, cell and gene therapy facilities, and\nresearch laboratory environments where even small variations in freezing\nconditions can affect product integrity and regulatory compliance.\n\nMarket Context\n\nDemand for ultra-low temperature freezing equipment continues to grow\nalongside expansion in biologics, cell and gene therapy, and blood product\nprocessing. Industry research estimates the global blast freezer market at\n$1.84 billion in 2025, growing to approximately $1.94 billion in 2026, and\nprojected to reach $2.58 billion by 2032 at a compound annual growth rate of\n4.89%. Separately, the global biomedical refrigerator and freezer market has\nbeen estimated at $4.34 billion in 2025, growing to approximately $4.8 billion\nin 2026 at a compound annual growth rate of 10.6%, with growth attributed in\npart to expanding vaccine storage needs, blood and plasma storage\nrequirements, and temperature-controlled drug development activity. Market\nsize estimates vary by research firm and market definition, and figures should\nbe considered directional rather than authoritative.\n\nAvailability\n\nPricing for the PF-90 is available upon request. Interested parties can\ncontact Cryometrix directly at (801) 226-4100 or info@cryometrix.com.\n\nAbout Reflect Scientific, Inc.\n\nReflect Scientific, Inc., based in Orem, Utah, develops and markets\ninnovative, proprietary technologies in cryogenic cooling for the\nbiotechnology, pharmaceutical, medical, and transportation markets. Among\nReflect Scientific’s products are low-temperature freezers and refrigerated\nsystems for laboratory, transportation, and computer server room uses. Visit\nreflectscientific.com (http://reflectscientific.com) for more information. See\nus on Twitter @ReflectSci and LinkedIn\nwww.linkedin.com/company/reflect-scientific.\n\nForward-Looking Statements\nThis press release contains forward-looking statements within the meaning of\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended. Forward-looking statements are\nnot a guarantee of future performance or results, and will not necessarily be\naccurate indications of the times at, or by, which such performance or results\nwill be achieved. Forward-looking statements are based on information\navailable at the time the statements are made and involve known and unknown\nrisks, uncertainties and other factors that may cause our results, levels of\nactivity, performance or achievements to be materially different from the\ninformation expressed or implied by the forward-looking statements in this\npress release. This press release should be considered in light of the\ndisclosures contained in the filings of the Company that are contained in the\nOTC Markets Group, LLC under the trading symbol “RSCF” and related prior\nfilings by the Company that are referenced therein and contained in the EDGAR\nArchives of the Securities and Exchange Commission under the heading\n“Disclosure,” including those identified in such filings as\n“forward-looking statements.”\n\nContact\nInvestor Relations\n801-607-1039\ninfo@reflectscientific.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/28066f8b-1063-44c2-9ce7-c35fa2d74e58)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-13T12:00:00.426412841Z","server_sent_at_ms":1791892800426},"received_at":"2026-10-13T12:00:00.477Z","source_url":null},"analysis":{"id":"155716","press_release_id":"167406","analysis_json":{"industry":{"label":"Electronic Equipment, Instruments & Components","sector":"Information Technology"},"redFlags":[],"eventType":"product_launch","narrative":"Reflect Scientific, through its Cryometrix brand, launched the PF-90 Blast Plate Freezer, combining liquid nitrogen blast freezing with conductive plate freezing in a single patent-pending ultra-low temperature unit.\n\nThe system targets biopharmaceutical, blood product, and cell and gene therapy facilities, with a 40°C to -90°C range, roughly 10-minute pull-down to -80°C, and a 20-year warranty on the cooling system.\n\nThe company cites a blast freezer market of $1.84 billion in 2025 growing to a projected $2.58 billion by 2032, though no orders, pricing, or revenue contribution were disclosed.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Micro-cap Cryometrix expands cold-chain product line with dual-technology PF-90 freezer for biologics and cell therapy."},"keyFigures":{"customDimensions":{"capacity":"up to 8 Sartorius Celsius FFTp 12 L bags per cycle; 192 L in bottles","warranty":"20 years on cooling system","temperature_range":"40°C to -90°C","blast_freezer_market_2025":"$1.84 billion","blast_freezer_market_cagr":"4.89%","pull_down_time_to_minus80":"approximately 10 minutes (empty payload bay)","blast_freezer_market_2032_projection":"$2.58 billion","biomedical_refrigerator_freezer_market_2025":"$4.34 billion","biomedical_refrigerator_freezer_market_cagr":"10.6%"}},"quotedText":"Plate freezing has become a necessary method for many biologics and blood product applications because it delivers faster heat transfer, improved uniformity across bag thickness, and reduced ice crystal formation","namedEntities":{"people":[],"products":["PF-90 Blast Plate Freezer"],"companies":[{"name":"Reflect Scientific, Inc.","ticker":"RSCF","relationship":"filer/manufacturer"},{"name":"Cryometrix","relationship":"brand of Reflect Scientific"},{"name":"Sartorius","relationship":"supplier (compatible freezer bags)"}],"dollarAmounts":[{"amount":"$1.84 billion","context":"global blast freezer market, 2025 estimate"},{"amount":"$1.94 billion","context":"global blast freezer market, 2026 estimate"},{"amount":"$2.58 billion","context":"projected global blast freezer market by 2032"},{"amount":"$4.34 billion","context":"global biomedical refrigerator and freezer market, 2025 estimate"},{"amount":"$4.8 billion","context":"global biomedical refrigerator and freezer market, 2026 estimate"}]},"materialImpact":{"score":2,"reasoning":"A new product launch (PF-90 Blast Plate Freezer) for a micro-cap OTC issuer. It expands the Cryometrix product line into biopharma/cell-therapy cold chain, but no revenue, orders, or backlog figures were disclosed, limiting near-term financial impact."},"tickerRelevance":{"others":[],"primary":"RSCF"},"globalImportance":10,"audienceRelevance":8,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap OTC","eventGravity":"routine product launch, no orders or financials disclosed","householdBrandBoost":false,"retailFavoriteBoost":false}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Reflect Scientific, through its Cryometrix brand, launched the PF-90 Blast Plate Freezer, combining liquid nitrogen blast freezing with conductive plate freezing in a single patent-pending ultra-low temperature unit.\n\nThe system targets biopharmaceutical, blood product, and cell and gene therapy facilities, with a 40°C to -90°C range, roughly 10-minute pull-down to -80°C, and a 20-year warranty on the cooling system.\n\nThe company cites a blast freezer market of $1.84 billion in 2025 growing to a projected $2.58 billion by 2032, though no orders, pricing, or revenue contribution were disclosed.","key_figures":{"customDimensions":{"capacity":"up to 8 Sartorius Celsius FFTp 12 L bags per cycle; 192 L in bottles","warranty":"20 years on cooling system","temperature_range":"40°C to -90°C","blast_freezer_market_2025":"$1.84 billion","blast_freezer_market_cagr":"4.89%","pull_down_time_to_minus80":"approximately 10 minutes (empty payload bay)","blast_freezer_market_2032_projection":"$2.58 billion","biomedical_refrigerator_freezer_market_2025":"$4.34 billion","biomedical_refrigerator_freezer_market_cagr":"10.6%"}},"named_entities":{"people":[],"products":["PF-90 Blast Plate Freezer"],"companies":[{"name":"Reflect Scientific, Inc.","ticker":"RSCF","relationship":"filer/manufacturer"},{"name":"Cryometrix","relationship":"brand of Reflect Scientific"},{"name":"Sartorius","relationship":"supplier (compatible freezer bags)"}],"dollarAmounts":[{"amount":"$1.84 billion","context":"global blast freezer market, 2025 estimate"},{"amount":"$1.94 billion","context":"global blast freezer market, 2026 estimate"},{"amount":"$2.58 billion","context":"projected global blast freezer market by 2032"},{"amount":"$4.34 billion","context":"global biomedical refrigerator and freezer market, 2025 estimate"},{"amount":"$4.8 billion","context":"global biomedical refrigerator and freezer market, 2026 estimate"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-13T12:00:06.815Z","global_importance":10,"audience_relevance":8,"importance_components":{"tickerTier":"micro-cap OTC","eventGravity":"routine product launch, no orders or financials disclosed","householdBrandBoost":false,"retailFavoriteBoost":false}},"durationMs":6313,"modelName":"glm-5.3-flashx"}}